The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,892 | 15,250 | 14,010 | 61,425 | 64,208 |
| Marketable Securities | 10,291 | 40,132 | 59,796 | 29,154 | N/A |
| Receivables | 46,893 | 46,384 | 40,433 | 35,379 | 29,369 |
| Inventories | 12,168 | 10,254 | 9,261 | 10,018 | 8,580 |
| TOTAL | $104,071 | $118,962 | $130,418 | $143,631 | $112,205 |
| Non-Current Assets | |||||
| PPE Net | 10,772 | 9,846 | 8,547 | 7,006 | 6,014 |
| Investments And Advances | 58,944 | 58,841 | 58,354 | 58,215 | 0 |
| Intangibles | 26,574 | 21,779 | 39,375 | 49,681 | 53,859 |
| Other Non-Current Assets | 29,598 | 25,205 | 24,971 | 25,269 | 17,662 |
| TOTAL | $125,888 | $115,671 | $131,247 | $140,171 | $77,535 |
| Total Assets | $229,959 | $234,633 | $261,665 | $283,802 | $189,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,123 | 11,946 | 9,372 | 11,155 | 13,900 |
| Accrued Expenses | 14,126 | 12,245 | 14,595 | 16,147 | 17,610 |
| TOTAL | $33,506 | $30,085 | $29,720 | $32,852 | $36,128 |
| Non-Current Liabilities | |||||
| Long Term Debt | 83,688 | 82,144 | 80,621 | 79,069 | N/A |
| Other Non-Current Liabilities | 27,965 | 23,916 | 28,041 | 43,393 | 29,127 |
| TOTAL | $111,731 | $106,142 | $108,770 | $123,016 | $29,629 |
| Total Liabilities | $145,237 | $136,227 | $138,490 | $155,868 | $65,757 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,955 | 75,351 | 74,552 | 72,342 | 72,140 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -109,977 | -93,080 | -63,082 | -52,075 | -49,401 |
| Other shareholders' equity | 106 | 0 | 0 | 0 | 0 |
| TOTAL | $84,722 | $98,406 | $123,175 | $127,934 | $123,983 |
| Total Liabilities And Equity | $229,959 | $234,633 | $261,665 | $283,802 | $189,740 |